The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.

RATIONALE Sphingosine kinases (SphKs) 1 and 2 regulate the synthesis of the bioactive sphingolipid sphingosine-1-phosphate (S1P), an important lipid mediator that promotes cell proliferation, migration, and angiogenesis. OBJECTIVES We aimed to examine whether SphKs and their product, S1P, play a role in the development of pulmonary arterial hypertension (PAH). METHODS SphK1(-/-), SphK2(-/-), and S1P lyase heterozygous (Sgpl1(+/-)) mice, a pharmacologic SphK inhibitor (SKI2), and a S1P receptor 2 (S1PR2) antagonist (JTE013) were used in rodent models of hypoxia-mediated pulmonary hypertension (HPH). S1P levels in lung tissues from patients with PAH and pulmonary arteries (PAs) from rodent models of HPH were measured. MEASUREMENTS AND MAIN RESULTS mRNA and protein levels of SphK1, but not SphK2, were significantly increased in the lungs and isolated PA smooth muscle cells (PASMCs) from patients with PAH, and in lungs of experimental rodent models of HPH. S1P levels were increased in lungs of patients with PAH and PAs from rodent models of HPH. Unlike SphK2(-/-) mice, SphK1(-/-) mice were protected against HPH, whereas Sgpl1(+/-) mice were more susceptible to HPH. Pharmacologic SphK1 and S1PR2 inhibition prevented the development of HPH in rodent models of HPH. Overexpression of SphK1 and stimulation with S1P potentially via ligation of S1PR2 promoted PASMC proliferation in vitro, whereas SphK1 deficiency inhibited PASMC proliferation. CONCLUSIONS The SphK1/S1P axis is a novel pathway in PAH that promotes PASMC proliferation, a major contributor to pulmonary vascular remodeling. Our results suggest that this pathway is a potential therapeutic target in PAH.

[1]  E. Hoffman,et al.  Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S 1 PR 2 / STAT 3 signaling pathway , 2016 .

[2]  Lan Liu,et al.  Sphingosine kinase 1 overexpression stimulates intestinal epithelial cell proliferation through increased c-Myc translation. , 2013, American journal of physiology. Cell physiology.

[3]  A. Baccarelli,et al.  ADCYAP1R1 and asthma in Puerto Rican children. , 2013, American journal of respiratory and critical care medicine.

[4]  Guodou Tang,et al.  Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. , 2013, International journal of oncology.

[5]  I. Noth,et al.  Targeting sphingosine kinase 1 attenuates bleomycin‐induced pulmonary fibrosis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  S. Bonnet,et al.  STAT3 signaling in pulmonary arterial hypertension , 2012, JAK-STAT.

[7]  A. Yamaguchi,et al.  Mouse SPNS2 Functions as a Sphingosine-1-Phosphate Transporter in Vascular Endothelial Cells , 2012, PloS one.

[8]  E. Hoffman,et al.  Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway , 2012, PloS one.

[9]  J. Garcia,et al.  Sphingosine Kinase 1 Deficiency Protects Rodents from Chronic Hypoxia-mediated Pulmonary Hypertension. , 2012, ATS 2012.

[10]  W. Li,et al.  Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal‐regulated kinase , 2012, Cell proliferation.

[11]  P. Bruni,et al.  Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors. , 2012, Biochimica et biophysica acta.

[12]  Eugene Y. Kim,et al.  Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. , 2012, Cancer research.

[13]  Yunchao Su,et al.  Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. , 2011, The Journal of clinical investigation.

[14]  J. Garcia,et al.  Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. , 2011, American journal of respiratory cell and molecular biology.

[15]  M. Tölle,et al.  Pharmacological relevance and potential of sphingosine 1‐phosphate in the vascular system , 2011, British journal of pharmacology.

[16]  M. Oka,et al.  S1P4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs , 2011, Pulmonary circulation.

[17]  J. Chun,et al.  S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells. , 2011, American journal of physiology. Cell physiology.

[18]  Mark A Sussman,et al.  Signal Transducers and Activators of Transcription-3/Pim1 Axis Plays a Critical Role in the Pathogenesis of Human Pulmonary Arterial Hypertension , 2011, Circulation.

[19]  J. Garcia,et al.  Intracellular S1P Generation Is Essential for S1P-Induced Motility of Human Lung Endothelial Cells: Role of Sphingosine Kinase 1 and S1P Lyase , 2011, PloS one.

[20]  S. Erzurum,et al.  Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension. , 2010, Comprehensive Physiology.

[21]  W. Argraves,et al.  Sphingosine-1-phosphate signaling in vasculogenesis and angiogenesis. , 2010, World journal of biological chemistry.

[22]  B. Pitt,et al.  S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[23]  Xiao-pei Gao,et al.  A Novel Function of Sphingosine Kinase 1 Suppression of JNK Activity in Preventing Inflammation and Injury* , 2010, The Journal of Biological Chemistry.

[24]  Takuya Shimizu,et al.  Sphingosine-1-Phosphate Receptor-2 Regulates Expression of Smooth Muscle Alpha-Actin After Arterial Injury , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[25]  A. Yoshimura,et al.  Sprouty4 deficiency potentiates Ras‐independent angiogenic signals and tumor growth , 2009, Cancer science.

[26]  Y. Zeng,et al.  Sphingosine Kinase 1 Is Associated with Gastric Cancer Progression and Poor Survival of Patients , 2009, Clinical Cancer Research.

[27]  Sarah Spiegel,et al.  Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells* , 2009, Journal of Biological Chemistry.

[28]  P. Heath,et al.  Sphingosine-1-phosphate mediates transcriptional regulation of key targets associated with survival, proliferation, and pluripotency in human embryonic stem cells. , 2008, Stem cells and development.

[29]  O. Nayler,et al.  bFGF induces S1P1 receptor expression and functionality in human pulmonary artery smooth muscle cells , 2008, Journal of cellular biochemistry.

[30]  O. Cuvillier,et al.  Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells. , 2008, Cancer research.

[31]  R. Dweik,et al.  High levels of hyaluronan in idiopathic pulmonary arterial hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[32]  S. Rennard,et al.  Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor. , 2008, American journal of respiratory cell and molecular biology.

[33]  S. Kaneko,et al.  G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. , 2008, Cardiovascular research.

[34]  G. Owens,et al.  Sphingosine-1-Phosphate Receptor Subtypes Differentially Regulate Smooth Muscle Cell Phenotype , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[35]  S. Milstien,et al.  “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets , 2008, Pharmacological Reviews.

[36]  J. Pfeilschifter,et al.  Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. , 2008, Biochemical and biophysical research communications.

[37]  L. Obeid,et al.  Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages. , 2008, Prostaglandins & other lipid mediators.

[38]  S. Erzurum,et al.  Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[39]  J. Garcia,et al.  Intracellular Generation of Sphingosine 1-Phosphate in Human Lung Endothelial Cells , 2007, Journal of Biological Chemistry.

[40]  J. Francy,et al.  Sphingosine kinase 1 expression is regulated by signaling through PI3K, AKT2, and mTOR in human coronary artery smooth muscle cells. , 2007, Biochimica et biophysica acta.

[41]  V. Natarajan,et al.  The functional PDGFβ receptor–S1P1 receptor signaling complex is involved in regulating migration of mouse embryonic fibroblasts in response to platelet derived growth factor , 2006 .

[42]  S. Pyne,et al.  The effect of hypoxia on lipid phosphate receptor and sphingosine kinase expression and mitogen-activated protein kinase signaling in human pulmonary smooth muscle cells. , 2006, Prostaglandins & other lipid mediators.

[43]  V. Natarajan,et al.  The functional PDGFbeta receptor-S1P1 receptor signaling complex is involved in regulating migration of mouse embryonic fibroblasts in response to platelet derived growth factor. , 2006, Prostaglandins & other lipid mediators.

[44]  R. Leach,et al.  Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry. , 2005, Cardiovascular research.

[45]  Korey R. Johnson,et al.  Immunohistochemical Distribution of Sphingosine Kinase 1 in Normal and Tumor Lung Tissue , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[46]  W. Haschek,et al.  Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[47]  J. Yuan,et al.  Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. , 2005, Circulation.

[48]  Yusuf A. Hannun,et al.  Biologically active sphingolipids in cancer pathogenesis and treatment , 2004, Nature Reviews Cancer.

[49]  Weicheng Wu,et al.  VEGF receptor expression and signaling in human bladder tumors , 2003, Oncogene.

[50]  A. Kihara,et al.  Sphingosine-1-phosphate Lyase Is Involved in the Differentiation of F9 Embryonal Carcinoma Cells to Primitive Endoderm* , 2003, The Journal of Biological Chemistry.

[51]  Mark J. Murphy,et al.  c-Myc regulates mammalian body size by controlling cell number but not cell size , 2001, Nature.

[52]  A. Verin,et al.  Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. , 2001, The Journal of clinical investigation.

[53]  J. Gamble,et al.  Expression of a Catalytically Inactive Sphingosine Kinase Mutant Blocks Agonist-induced Sphingosine Kinase Activation , 2000, The Journal of Biological Chemistry.

[54]  S. Milstien,et al.  Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform* , 2000, The Journal of Biological Chemistry.

[55]  T. Bleu,et al.  Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5* , 2000, The Journal of Biological Chemistry.

[56]  T Watanabe,et al.  Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. , 2000, The Biochemical journal.

[57]  S. Spiegel,et al.  Sphingosine Kinase Expression Increases Intracellular Sphingosine-1-Phosphate and Promotes Cell Growth and Survival , 1999, The Journal of cell biology.

[58]  S. Spiegel,et al.  Dual Actions of Sphingosine-1-Phosphate: Extracellular through the Gi-coupled Receptor Edg-1 and Intracellular to Regulate Proliferation and Survival , 1998, The Journal of cell biology.

[59]  E. Kostetsky,et al.  A universal reagent for phospholipid analysis. , 1975, Journal of chromatography.